DBV Technologies (DBVTF) Stock Price, Quote, News & History

DBV Technologies SA (DBVTF) Stock Price, Quote, News & History

DBVTFOTCPK

Trade with Public

$4.30

At close: Apr 10, 5:00 PM EST

Key Statistics

Open

Volume / Avg.

0 / 300.00

Day Range

- - -

52 Wk Range

0.00 - 4.80

Market Cap

$1.27B

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Dbv Technologies SA News

Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch

DBV Technologies (NASDAQ: DBVT) (OTC:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-121.18M

Investing Cash Flow (TTM)

-1.37M

Financing Cash Flow (TTM)

276.18M

Free Cash Flow (TTM)

-121.72M

Capital Expenditure (TTM)

-538.00K

Net Change in Cash (TTM)

153.63M

Valuation Metrics

Enterprise Value

$1.03B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

7.54

Earnings Yield % (TTM)

-24.42%

Earnings Yield % (FWD)

-12.24%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.57

Company Debt

Total Debt

$1.47M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$194.17M

Debt to Equity

0.05

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 300.00

Day Range

- - -

52 Wk Range

0.00 - 4.80

Market Cap

$1.27B

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DBV Technologies (DBVTF) stock?

You can purchase shares of DBV Technologies (OTCPK:DBVTF) through any online brokerage.

View our list of the best stock brokerages

Who are DBV Technologies (DBVTF) competitors?

There are no as such competitors for DBV Technologies.

What is the forecast, or price target, for DBV Technologies (DBVTF) stock?

There is no analysis for DBV Technologies to provide a consensus price target.

What is the current price for DBV Technologies (DBVTF)?

The stock price for DBV Technologies (OTCPK: DBVTF) is $4.3 last updated March 11, 2026 at 3:56 PM EDT.

Does DBV Technologies (DBVTF) pay a dividend?

There are no upcoming dividends for DBV Technologies.

When is DBV Technologies (OTCPK:DBVTF) reporting earnings?

DBV Technologies does not have any upcoming earnings scheduled.

Is DBV Technologies (DBVTF) going to split?

There is no upcoming split for DBV Technologies.

What sector and industry does DBV Technologies (DBVTF) operate in?

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

0 / 300.00

Day Range

- - -

52 Wk Range

0.00 - 4.80

Market Cap

$1.27B

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Dbv Technologies SA News

Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch

DBV Technologies (NASDAQ: DBVT) (OTC:

Vandana Singh